CN104857559A - Bone repair product with degradable copolymer-calcium silicate composite bone repair materials serving as raw materials - Google Patents

Bone repair product with degradable copolymer-calcium silicate composite bone repair materials serving as raw materials Download PDF

Info

Publication number
CN104857559A
CN104857559A CN201510219762.5A CN201510219762A CN104857559A CN 104857559 A CN104857559 A CN 104857559A CN 201510219762 A CN201510219762 A CN 201510219762A CN 104857559 A CN104857559 A CN 104857559A
Authority
CN
China
Prior art keywords
copolymer
calcium silicates
bone repair
bone
goods
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CN201510219762.5A
Other languages
Chinese (zh)
Other versions
CN104857559B (en
Inventor
章飞
赵永飞
刘铁龙
邹薇薇
孔金海
赵成龙
王静
高欣
杨诚
肖建如
魏杰
李鸿
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Department of orthopedics, Beilun Ningbo hospital
Shanghai Changzheng Hospital
Original Assignee
NINGBO DEVELOPMENT ZONE CENTER HOSPITAL
Shanghai Changzheng Hospital
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by NINGBO DEVELOPMENT ZONE CENTER HOSPITAL, Shanghai Changzheng Hospital filed Critical NINGBO DEVELOPMENT ZONE CENTER HOSPITAL
Priority to CN201510219762.5A priority Critical patent/CN104857559B/en
Publication of CN104857559A publication Critical patent/CN104857559A/en
Application granted granted Critical
Publication of CN104857559B publication Critical patent/CN104857559B/en
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Abstract

The invention discloses a bone repair product with degradable copolymer-calcium silicate composite bone repair materials serving as raw materials. The composite bone repair materials are composed of degradable lactic acid-basic amino acid copolymers and calcium silicate. The calcium silicate occupies 25% to 40% of the total mass of the bone repair materials, and the lactic acid-basic amino acid copolymers is formed by polymerization of L-lactic acid and at least one alpha-basic amino acid, wherein the basic amino acid is 5% to 30% of the total molar weight of the copolymers. The bone repair product is degradable in bodies and capable of providing calcium and silicon ions for bone tissues, high in biological activity; apparent advantages are provided in aspects of promotion of collagen synthesis, cell proliferation and differentiation and the like; degradation products has no obvious effect on surroundings.

Description

Biodegradable block copolymer-calcium silicates composite bone repairing material is the Bone Defect Repari goods of raw material
The application is the applying date: on January 25th, 2015, application number: 201510034938.X, denomination of invention: the divisional application of the patent application of biodegradable block copolymer-calcium silicates composite bone repairing material and preparation method.
Technical field
The present invention relates to a kind of Bone Defect Repari goods for osseous tissue defect repair, the Bone Defect Repari goods of to be specifically biodegradable block copolymer-calcium silicates composite bone repairing material be raw material.
Background technology
In osseous tissue agglutination, under the effect of degradable biological material water and enzyme in body fluid, formative tissue can enter (growth)-material and move back the desired tissue reproduced state of (degraded or absorb) and be subject to extensive concern.With regard to degradable high polymer material, comprise the degradable high polymer material as synthetic such as polylactic acid, lactic acid-acetate multipolymer, polyamino acid, polycaprolactone, polyvinyl alcohol, and large class such as degradable macromolecule two as natural in chitosan, chitin, protein, collagen etc.The equal degradable of these macromolecular materials, and degradation speed can by realizations such as Molecular regulator amount, crystal habits.But as the bone renovating material used time, these macromolecular materials exist more mechanical strength difference, degradation property not good, there is the shortcomings such as immunological rejection.And the macromolecular material of single composition can not provide when repairing osseous tissue and promotes the calcium ion of skeletonization and phosphate anion, lack good osteogenic activity.
For this reason, degradable high polymer material with there is the degradable composite material that bioactive calcium microcosmic salt is composited, be the hot fields of current bone renovating material.As polylactic acid-calcium phosphate, polylactic acid-glycolic base apatite composite material, polyamino acid-calcium sulfate, polyamino acid-calcium phosphate, polyamino acid-hydroxyapatite, polyamino acid-calcium silicates, and collagen-hydroxyapatite composite etc., wherein only collagen-hydroxyapatite composite is current for clinical.In this kind of material, collagen may produce immunological rejection, and the mechanical property of its composite is not good; Polylactic acid-calcium salt composite produces acid lactic acid in degradation process, easily causes aseptic inflammation; In polyamino acid-calcium salt composite the solubility property of polyamino acid and processability still not ideal enough.
Macromolecule in degradable composite bone repairing material mutually in, lactic acid be can by fermentation mode obtain, its source is unrestricted, and during synthetic, its composition, purity are all controlled.The polylactic acid formed after lactic acid copolymerization is a kind of macromolecular material with good degradation property, and anti-film, Absorbable plate and the plate etc. of being adhered in its product are in clinical a large amount of use.But along with the quantity of clinical practice increases and time lengthening, the shortcoming of polylactic acid also starts to manifest, degradation speed as Pfansteihl copolymer is too fast, and after implanting, its catabolite lactic acid easily causes the inflammatory reaction of local, makes application be subject to great restriction.Thus, study more preferably degradable composite material and become an important problem.
Summary of the invention
For above-mentioned situation, the invention provides a kind of Bone Defect Repari goods of degradable composite bone repairing material of new model, the Bone Defect Repari goods of to be specifically a kind of biodegradable block copolymer-calcium silicates composite bone repairing material be raw material.
Biodegradable block copolymer of the present invention-calcium silicates composite bone repairing material is the Bone Defect Repari goods of raw material, wherein, biodegradable block copolymer-calcium silicates composite bone repairing material is made up of degradable lactic acid-basic amine group acid copolymer and calcium silicates compound, wherein calcium silicates is 25 ~ 40% of described bone renovating material gross mass, lactic acid-basic amine group acid copolymer is polymerized by Pfansteihl and at least one α-basic amino acid, and wherein basic amino acid is 5 ~ 30% of copolymer integral molar quantity.
Wherein, in described biodegradable block copolymer-calcium silicates composite bone repairing material, basic amino acid is at least one in lysine, histidine, arginine.
Wherein, in described biodegradable block copolymer-calcium silicates composite bone repairing material, lysine is 5 ~ 30% of copolymer integral molar quantity, and histidine is 5 ~ 20% of copolymer integral molar quantity, and arginine is 5 ~ 10% of copolymer integral molar quantity.
Wherein, in described biodegradable block copolymer-calcium silicates composite bone repairing material, basic amino acid is 15 ~ 30% of copolymer integral molar quantity.
Wherein, described calcium silicates is 25 ~ 40% of described bone renovating material gross mass.
Wherein, the Bone Defect Repari goods comprising bar, block, bar form of what described biodegradable block copolymer-calcium silicates composite bone repairing material was processed into meet Clinical practice needs.
Biodegradable block copolymer of the present invention-calcium silicates composite bone repairing material, studies verified, and the calcium ion in vivo after release is conducive to skeletonization, and can form biological activity interface between material and tissue.At present for the bioactive ingredients used in osseous tissue composite, what usually adopt is hydroxyapatite and tricalcium phosphate, also includes calcium sulfate, calcium hydrogen phosphate and part organic calcium salt etc.Comparative study in recent years finds, when siliceous calcium salt uses as bone renovating material, higher biological activity can be had relative to aforementioned not siliceous salt, element silicon is wherein at promotion collage synthesis and promote to have obvious effect in cell proliferation and differentiation, and silicon, calcium are when existing simultaneously, it is more obviously better than independent calcium microcosmic salt to biological cells and tissues growth aspect.Based on this, in composite bone repairing material of the present invention, have employed calcium silicates as inorganic active composition.Experiment display, exceed the scope that above-mentioned calcium silicates is described bone renovating material gross mass 10 ~ 50%, higher calcium silicates content can make composite material exhibits go out more obvious fragility, and is unfavorable for follow-up extrusion molding and injection molding molding; The calcium silicates crossing low content then can affect the biological activity of composite.Wherein, the better ratio of calcium silicates can be chosen as 25 ~ 40% of bone renovating material gross mass, is conducive to making composite take into account good biological activity and good toughness better.
Because the present invention's above-mentioned biodegradable block copolymer-calcium silicates composite bone repairing material can be degraded in vivo, the basic amino acid therefore described in material, preferably can be at least one in the lysine of absorption of human body utilization, histidine, arginine.
Basic amino acid is used in composite bone repairing material of the present invention, except scalable and the degradation speed changing copolymer, the basic amino acid produced after particularly making material degradation in vivo and the acidity of lactic acid neutralize mutually, to reduce the stimulation of catabolite to tissue.Because the pH value of Different Alkali acidic amino acid there are differences, for above-mentioned preferred three kinds of basic amino acids, the pH value of arginine self is the highest, for strong basicity aminoacid, the pH value of histidine and lysine is then relatively low, therefore for reaching better and the acidity of lactic acid, the actual use amount of Different Alkali acidic amino acid can appropriately adjust according to the alkalescence height of basic amino acid used.Such as, for above-mentioned three kinds of basic amino acids, described lysine is preferably 5 ~ 30% of copolymer integral molar quantity, and histidine is preferably 5 ~ 20% of copolymer integral molar quantity, arginine is then preferably 5 ~ 10% of copolymer integral molar quantity, can obtain comparatively ideal copolymer.
Test display, the amino acid whose total amount of copolymer neutral and alkali is too low, is difficult to the performance that can change copolymer, and can causes the molecular weight and molecular weight of copolymer during too high levels, and easily forms intermolecular hydrogen bond, is unfavorable for the degraded of copolymer.Therefore in above-mentioned copolymer, better basic amino acid ratio can be chosen as 15 ~ 25% of copolymer integral molar quantity.
With the above-mentioned biodegradable block copolymer-calcium silicates composite bone repairing material of the present invention for raw material, through the processing mode such as extrusion molding or injection moulding of routine, namely may be made in corresponding Bone Defect Repari goods.Such as, what can be processed into meets the Bone Defect Repari goods comprising bar, block, bar form facing and use needs.
As above-mentioned, biodegradable block copolymer of the present invention-calcium silicates composite bone repairing material is the Bone Defect Repari goods of raw material, can degrade in vivo, catabolite not only has no significant effect surrounding, and higher bioactive calcium, silicon ion can be had for osseous tissue provides, in promotion collage synthesis, cell proliferation and differentiation etc., have advantage more more obvious than currently reported similar Bone Defect Repari goods, have be worth greatly and development, application prospect.
Detailed description of the invention below in conjunction with drawings and Examples is described in further detail foregoing of the present invention again.But this should be interpreted as that the scope of the above-mentioned theme of the present invention is only limitted to following example.Without departing from the idea case in the present invention described above, the various replacement made according to ordinary skill knowledge and customary means or change, all should comprise within the scope of the invention.
Accompanying drawing explanation
Fig. 1 is the comparing result of material of the present invention and control material cell proliferation test.
Fig. 2 is the comparing result that material of the present invention and control material cell differentiation are tested.
Fig. 3 artificial neural plate.
Fig. 4 cervical vertebral fusion cage.
Fig. 5 vertebral body goods.
Detailed description of the invention
Embodiment 1
By 0.8 molar lactic acid, 0.1 mole of lysine, 0.05 mole of histidine, 0.05 mole of arginine, and the catalyst stannous chloride of reactant gross mass 0.4% adds in reactor, stirs, and keeps pressure 0.1Mpa, is warming up to 120 DEG C ± 5 DEG C, dewaters 2 hours; Be warming up to 140 DEG C ± 5 DEG C, in first 3 hours of reaction, keep pressure 0.01Mpa, keep pressure 5000Pa afterwards and continue reaction 12 hours; Afterwards, be warming up to 180 DEG C-200 DEG C, pressure 70Pa, react 8 hours; Then add calcium silicates, similarity condition continues reaction 2 hours, is cooled to room temperature and obtains composite.
Materials processing is become diameter 10mm, the disk of height 2mm carries out Degrading experiment.Using phosphate buffer as soak, disk is soaked, sample quality: soak volume is 1g:30ml.After soaking 12 weeks, material weight-loss ratio reaches 58%, and soak pH fluctuates within the scope of 6.9-7.3.
Embodiment 2
By 0.7 molar lactic acid, 0.1 mole of lysine, 0.1 mole of histidine, the catalyst stannous chloride of 0.1 mole of arginine and reactant gross mass 0.4% adds in reactor, stirs, and keeps pressure 0.1Mpa, is warming up to 120 DEG C ± 5 DEG C, dewaters 2 hours; Be warming up to 140 DEG C ± 5 DEG C, in first 3 hours of reaction, keep pressure 0.01Mpa, keep pressure 5000Pa afterwards and continue reaction 12 hours; Afterwards, be warming up to 180 DEG C-200 DEG C, pressure 70Pa, react 8 hours; Then add calcium silicates, similarity condition continues reaction 2 hours, is cooled to room temperature and obtains composite.
Degrading experiment condition is with example 1.After soaking 12 weeks, material weight-loss ratio reaches 48%, and soak pH fluctuates within the scope of 6.9-7.5.
Embodiment 3
By 0.95 molar lactic acid, 0.05 mole of arginine, and the catalyst stannous chloride of reactant gross mass 0.4% adds in reactor, stirs, and keeps pressure 0.1Mpa, is warming up to 120 DEG C ± 5 DEG C, dewaters 2 hours; Be warming up to 140 DEG C ± 5 DEG C, in first 3 hours of reaction, keep pressure 0.01Mpa, keep pressure 5000Pa afterwards and continue reaction 12 hours; Afterwards, be warming up to 180 DEG C-200 DEG C, pressure 70Pa, react 8 hours; Then add calcium silicates, similarity condition continues reaction 2 hours, is cooled to room temperature and obtains composite.
Degrading experiment condition is with example 1.After soaking 12 weeks, material weight-loss ratio reaches 65%, and soak pH fluctuates within the scope of 7.1-7.7.
Embodiment 4
By 0.7 molar lactic acid, 0.3 mole of lysine, and the catalyst stannous chloride of reactant gross mass 0.3% adds in reactor, stirs, and keeps pressure 0.1Mpa, is warming up to 120 DEG C ± 5 DEG C, dewaters 2 hours; Be warming up to 140 DEG C ± 5 DEG C, in first 3 hours of reaction, keep pressure 0.01Mpa, keep pressure 5000Pa afterwards and continue reaction 12 hours; Afterwards, be warming up to 180 DEG C-200 DEG C, pressure 70Pa, react 8 hours; Then add calcium silicates, similarity condition continues reaction 2 hours, is cooled to room temperature and obtains composite.
Degrading experiment condition is with example 1.After soaking 12 weeks, material weight-loss ratio reaches 45%, and soak pH fluctuates within the scope of 7.0-7.4.
Embodiment 5
By 0.95 molar lactic acid, 0.05 mole of lysine, and the catalyst stannous chloride of reactant gross mass 0.6% adds in reactor, stirs, and keeps pressure 0.1Mpa, is warming up to 120 DEG C ± 5 DEG C, dewaters 2 hours; Be warming up to 140 DEG C ± 5 DEG C, in first 3 hours of reaction, keep pressure 0.01Mpa, keep pressure 5000Pa afterwards and continue reaction 7 hours; Afterwards, be warming up to 180 DEG C-200 DEG C, pressure 70Pa, react 6 hours; Then add calcium silicates, similarity condition continues reaction 2 hours, is cooled to room temperature and obtains composite.
Degrading experiment condition is with example 1.After soaking 12 weeks, material weight-loss ratio reaches 85%, and soak pH fluctuates within the scope of 6.2-6.9.
Embodiment 6
By 0.95 molar lactic acid, 0.5 mole of lysine, and the catalyst stannous chloride of reactant gross mass 0.6% adds in reactor, stirs, and keeps pressure 0.1Mpa, is warming up to 120 DEG C ± 5 DEG C, dewaters 2 hours; Be warming up to 140 DEG C ± 5 DEG C, in first 3 hours of reaction, keep pressure 0.01Mpa, keep pressure 5000Pa afterwards and continue reaction 12 hours; Afterwards, be warming up to 180 DEG C-200 DEG C, pressure 70Pa, react 8 hours; Then add calcium silicates, similarity condition continues reaction 2 hours, is cooled to room temperature and obtains composite.
Degrading experiment condition is with example 1.After soaking 12 weeks, material weight-loss ratio reaches 35%, and soak pH fluctuates within the scope of 6.6-7.2.
Embodiment 7
Composite prepared by Example 1 ~ 6, adopts conventional injection moulding, hot pressing or general mach mode to prepare the product of clinical required various shapes.
Injection moulding is generally used for preparing thin, the erose goods of thickness.Be described to prepare Fig. 3 artificial neural plate.First according to article shape processing mold, then install on injection machine by mould, setting goods injection temperature, its scope is 140 DEG C-185 DEG C, and setting injection pressure, its scope is 40-90Mpa.Carry out injection moulding with this understanding and can obtain injection-molded item.
Hot-press method is that composite powder is put into mould, and then in certain temperature range, plasticizing can obtain goods.For the cervical vertebral fusion cage of preparation as Fig. 4, loaded by composite powder in mould, in the scope of 170 DEG C ± 5 DEG C, plasticizing 5-10 minute, can obtain corresponding goods after being cooled to room temperature.
Machine-tooled method utilizes the block of the composite of synthesis to prepare goods by modes such as car, milling, plane, mill, brills.Namely vertebral body goods shown in Fig. 5 are prepared by machining mode.
Comparative example 1
(lactic acid-amino acid)/calcium silicates (LA-AA/CaSiO that embodiment 1 is obtained 3) material (print group), with (lactic acid-amino acid)/hydroxyapatite (LA-AA/HA) (matched group) that prepare with the same terms, cell proliferation test and cell differentiation test have been carried out in contrast.Found that, in cultivation after 1,3,5,7 days, as shown in Figure 1, the result (alkali phosphatase index) of cell differentiation test as shown in Figure 2 for the result of the cell proliferation test of sample sets.The result of two tests all shows, and the result of material sample group of the present invention is all significantly better than matched group.In figure: * all represents that the result of sample sets and matched group has significant difference.

Claims (6)

1. biodegradable block copolymer-calcium silicates composite bone repairing material is the Bone Defect Repari goods of raw material, wherein, biodegradable block copolymer-calcium silicates composite bone repairing material is made up of degradable lactic acid-basic amine group acid copolymer and calcium silicates compound, wherein calcium silicates is 25 ~ 40% of described bone renovating material gross mass, lactic acid-basic amine group acid copolymer is polymerized by Pfansteihl and at least one α-basic amino acid, and wherein basic amino acid is 5 ~ 30% of copolymer integral molar quantity.
2. Bone Defect Repari goods as claimed in claim 1, is characterized in that, in described biodegradable block copolymer-calcium silicates composite bone repairing material, basic amino acid is at least one in lysine, histidine, arginine.
3. Bone Defect Repari goods as claimed in claim 2, it is characterized in that in described biodegradable block copolymer-calcium silicates composite bone repairing material, lysine is 5 ~ 30% of copolymer integral molar quantity, and histidine is 5 ~ 20% of copolymer integral molar quantity, and arginine is 5 ~ 10% of copolymer integral molar quantity.
4. the Bone Defect Repari goods as described in one of claims 1 to 3, is characterized in that, in described biodegradable block copolymer-calcium silicates composite bone repairing material, basic amino acid is 15 ~ 30% of copolymer integral molar quantity.
5. the Bone Defect Repari goods as described in one of Claims 1-4, is characterized in that in described biodegradable block copolymer-calcium silicates composite bone repairing material, and calcium silicates is 25 ~ 40% of described bone renovating material gross mass.
6. the Bone Defect Repari goods as described in one of Claims 1 to 5, is characterized in that the Bone Defect Repari goods comprising bar, block, bar form meeting Clinical practice needs be processed into by described biodegradable block copolymer-calcium silicates composite bone repairing material.
CN201510219762.5A 2015-01-25 2015-01-25 Bone repair product with degradable copolymer-calcium silicate composite bone repair materials serving as raw materials Expired - Fee Related CN104857559B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201510219762.5A CN104857559B (en) 2015-01-25 2015-01-25 Bone repair product with degradable copolymer-calcium silicate composite bone repair materials serving as raw materials

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CN201510219762.5A CN104857559B (en) 2015-01-25 2015-01-25 Bone repair product with degradable copolymer-calcium silicate composite bone repair materials serving as raw materials
CN201510034938.XA CN104524630A (en) 2015-01-25 2015-01-25 Degradable copolymer-calcium silicate composite bone repair material and preparation method thereof

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
CN201510034938.XA Division CN104524630A (en) 2015-01-25 2015-01-25 Degradable copolymer-calcium silicate composite bone repair material and preparation method thereof

Publications (2)

Publication Number Publication Date
CN104857559A true CN104857559A (en) 2015-08-26
CN104857559B CN104857559B (en) 2017-01-18

Family

ID=52840376

Family Applications (3)

Application Number Title Priority Date Filing Date
CN201510219762.5A Expired - Fee Related CN104857559B (en) 2015-01-25 2015-01-25 Bone repair product with degradable copolymer-calcium silicate composite bone repair materials serving as raw materials
CN201510034938.XA Pending CN104524630A (en) 2015-01-25 2015-01-25 Degradable copolymer-calcium silicate composite bone repair material and preparation method thereof
CN201510216660.8A Expired - Fee Related CN104841011B (en) 2015-01-25 2015-01-25 The preparation method of biodegradable block copolymer-calcium silicates composite bone repairing material

Family Applications After (2)

Application Number Title Priority Date Filing Date
CN201510034938.XA Pending CN104524630A (en) 2015-01-25 2015-01-25 Degradable copolymer-calcium silicate composite bone repair material and preparation method thereof
CN201510216660.8A Expired - Fee Related CN104841011B (en) 2015-01-25 2015-01-25 The preparation method of biodegradable block copolymer-calcium silicates composite bone repairing material

Country Status (1)

Country Link
CN (3) CN104857559B (en)

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104524630A (en) * 2015-01-25 2015-04-22 宁波开发区中心医院 Degradable copolymer-calcium silicate composite bone repair material and preparation method thereof
CN106620871A (en) * 2017-01-09 2017-05-10 中国人民解放军第二军医大学第二附属医院 Bone repairing product taking degradable copolymer-calcium silicate composite bone repairing material enhanced by hydroxyapatite whisker as raw material
CN106730024A (en) * 2017-01-09 2017-05-31 中国人民解放军第二军医大学第二附属医院 Hydroxyapatite crystal whisker strengthens biodegradable block copolymer calcium silicates composite bone repairing material
CN106880875A (en) * 2017-01-09 2017-06-23 中国人民解放军第二军医大学第二附属医院 Hydroxyapatite crystal whisker strengthens the preparation method of biodegradable block copolymer calcium silicates composite bone repairing material

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN109010908A (en) * 2018-10-17 2018-12-18 广州润虹医药科技股份有限公司 A kind of drug controlled-releasing function activity artificial bone and preparation method thereof

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20070128245A1 (en) * 2005-12-06 2007-06-07 Rosenberg Aron D Porous calcium phosphate bone material
CN104524630A (en) * 2015-01-25 2015-04-22 宁波开发区中心医院 Degradable copolymer-calcium silicate composite bone repair material and preparation method thereof

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN100391418C (en) * 2004-03-05 2008-06-04 中国科学院上海硅酸盐研究所 Bioactive composite cytoskeleton made of degradable porous polyester/calcium silicate, prepn. method and use thereof
KR101041784B1 (en) * 2009-06-26 2011-06-17 (주)시지바이오 Bone-repair composition
CN102824657B (en) * 2011-07-29 2014-05-21 深圳先进技术研究院 Bone restoration material and preparation method thereof

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20070128245A1 (en) * 2005-12-06 2007-06-07 Rosenberg Aron D Porous calcium phosphate bone material
CN104524630A (en) * 2015-01-25 2015-04-22 宁波开发区中心医院 Degradable copolymer-calcium silicate composite bone repair material and preparation method thereof

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104524630A (en) * 2015-01-25 2015-04-22 宁波开发区中心医院 Degradable copolymer-calcium silicate composite bone repair material and preparation method thereof
CN106620871A (en) * 2017-01-09 2017-05-10 中国人民解放军第二军医大学第二附属医院 Bone repairing product taking degradable copolymer-calcium silicate composite bone repairing material enhanced by hydroxyapatite whisker as raw material
CN106730024A (en) * 2017-01-09 2017-05-31 中国人民解放军第二军医大学第二附属医院 Hydroxyapatite crystal whisker strengthens biodegradable block copolymer calcium silicates composite bone repairing material
CN106880875A (en) * 2017-01-09 2017-06-23 中国人民解放军第二军医大学第二附属医院 Hydroxyapatite crystal whisker strengthens the preparation method of biodegradable block copolymer calcium silicates composite bone repairing material

Also Published As

Publication number Publication date
CN104841011A (en) 2015-08-19
CN104857559B (en) 2017-01-18
CN104841011B (en) 2017-01-04
CN104524630A (en) 2015-04-22

Similar Documents

Publication Publication Date Title
CN104857559A (en) Bone repair product with degradable copolymer-calcium silicate composite bone repair materials serving as raw materials
Negrini et al. Three-dimensional printing of chemically crosslinked gelatin hydrogels for adipose tissue engineering
Zhao et al. Biomimetic composite scaffolds to manipulate stem cells for aiding rheumatoid arthritis management
CN104324415B (en) Polybasic amino acids polymer-hydroxyl apatite bone repairing material, support type implant and preparation method
US7758803B2 (en) Resorbable macroporous bioactive glass scaffold and method of manufacture
Qian et al. Promoting bone regeneration of calcium phosphate cement by addition of PLGA microspheres and zinc silicate via synergistic effect of in-situ pore generation, bioactive ion stimulation and macrophage immunomodulation
CN1951964B (en) Long chain recombinant human bone morphogenesis protein-2 and its preparation method and uses
CN101342384A (en) Composite polymer bone-renovation material containing ceramic component and preparation method thereof
WO2016070500A1 (en) Controllably degradable multi-(amino acid) copolymer-organic calcium/phosphor salt filling-type composite bone implant and preparation method
Safari et al. A bioactive porous scaffold containing collagen/phosphorous-modified polycaprolactone for osteogenesis of adipose-derived mesenchymal stem cells
CN110540404A (en) calcium phosphate bone cement with hollow through structure, preparation method and application thereof
CN102357262A (en) Porous composite scaffold of PLLA (polylactic acid)/pearl powder and its preparation method
CN106798949A (en) A kind of porous hydroxyapatite bone renovating material and preparation method thereof
CN101716371A (en) Bracket material of bone tissue engineering of self-promoting vascularizing strontium-doped calcium polyphosphate and preparation method
CN105797211A (en) Preparation method of hydrogel, osteoblast containing hydrogel and preparation method of osteoblast containing hydrogel
CN106810689A (en) Bioabsorbable polyphosphate amino acid copolymer material
CN111388752B (en) PVA fiber/polyamino acid/hydroxyapatite bone supporting material and preparation thereof
CN106620871A (en) Bone repairing product taking degradable copolymer-calcium silicate composite bone repairing material enhanced by hydroxyapatite whisker as raw material
CN100355468C (en) Gene recombination spider's thread protein high polymer organizational engineering porous stent material
CN109437826B (en) Magnesium phosphate bone cement capable of being printed in 3D mode and preparation method and application thereof
Ko et al. Preparation of open porous hyaluronic acid scaffolds for tissue engineering using the ice particulate template method
CN101560326A (en) Amino acid copolymer-calcium sulfate composite material and preparation method thereof
US20180071433A1 (en) Bone graft with a tannin-hydroxyapatite scaffold and stem cells for bone engineering
CN106823010A (en) The purposes of bioabsorbable polyphosphate amino acid copolymer material
Medvecky et al. Osteogenic potential and properties of injectable silk fibroin/tetracalcium phosphate/monetite composite powder biocement systems

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
EXSB Decision made by sipo to initiate substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
C41 Transfer of patent application or patent right or utility model
GR01 Patent grant
TA01 Transfer of patent application right

Effective date of registration: 20161228

Address after: 315800 Ningbo, Zhejiang Province Feng Yang Road, Beilun District No. 458

Applicant after: Department of orthopedics, Beilun Ningbo hospital

Applicant after: Changzheng Hospital, Shanghai

Address before: BeiCang xinqie street Huashan road 315800 Zhejiang city of Ningbo province No. 666

Applicant before: NINGBO DEVELOPMENT ZONE CENTER HOSPITAL

Applicant before: Changzheng Hospital, Shanghai

CF01 Termination of patent right due to non-payment of annual fee
CF01 Termination of patent right due to non-payment of annual fee

Granted publication date: 20170118

Termination date: 20180125